Tibet Rhodiola Pharmaceutical Holding Co Cash Flow Reinvestment Rate
Tibet Rhodiola Pharmaceutical Holding Co cash flow reinvestment rate. Tibet Rhodiola Pharmaceutical Holding Co (600211) has a Cash Flow Reinvestment Rate of 0.07x as of December 2025, reinvesting CN¥20.26 Million (capex CN¥4.98 Million plus investments CN¥15.27 Million) from operating cash flow of CN¥297.86 Million. Explore Tibet Rhodiola Pharmaceutical Holding Co cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Tibet Rhodiola Pharmaceutical Holding Co (1999–2025)
Cash flow reinvestment rate of Tibet Rhodiola Pharmaceutical Holding Co from 1999 to 2025. Historical reinvestment intensity for Tibet Rhodiola Pharmaceutical Holding Co across 25 annual periods. Explore 600211 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Tibet Rhodiola Pharmaceutical Holding Co Cash Flow Reinvestment Rate by Year (1999–2025)
Tibet Rhodiola Pharmaceutical Holding Co cash flow reinvestment rate by year from 1999 to 2025. Year-by-year capital reinvestment analysis for Tibet Rhodiola Pharmaceutical Holding Co. For the full cash flow conversion analysis, see Tibet Rhodiola Pharmaceutical Holding Co (600211) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.73x | CN¥751.90 Million | CN¥1.03 Billion | CN¥15.96 Million | ▲ +70.7% |
| 2024 | 0.43x | CN¥426.90 Million | CN¥994.79 Million | CN¥37.60 Million | ▼ -45.6% |
| 2023 | 0.79x | CN¥853.57 Million | CN¥1.08 Billion | CN¥21.69 Million | ▲ +15.1% |
| 2022 | 0.69x | CN¥573.65 Million | CN¥837.38 Million | CN¥101.96 Million | ▼ -67.0% |
| 2021 | 2.08x | CN¥760.55 Million | CN¥366.53 Million | CN¥425.58 Million | ▲ +77.2% |
| 2020 | 1.17x | CN¥501.29 Million | CN¥428.17 Million | CN¥221.29 Million | ▲ +150.3% |
| 2019 | 0.47x | CN¥229.00 Million | CN¥489.59 Million | CN¥49.00 Million | ▼ -33.5% |
| 2018 | 0.70x | CN¥203.37 Million | CN¥289.22 Million | CN¥23.37 Million | ▼ -90.5% |
| 2017 | 7.41x | CN¥677.98 Million | CN¥91.46 Million | CN¥607.98 Million | ▲ +446.0% |
| 2016 | 1.36x | CN¥339.72 Million | CN¥250.21 Million | CN¥9.64 Million | ▼ -41.8% |
| 2015 | 2.33x | CN¥312.46 Million | CN¥133.93 Million | CN¥10.66 Million | ▲ +1809.4% |
| 2013 | 0.12x | CN¥34.12 Million | CN¥279.22 Million | CN¥34.12 Million | ▲ +55.4% |
| 2012 | 0.08x | CN¥4.42 Million | CN¥56.20 Million | CN¥4.42 Million | ▼ -58.9% |
| 2011 | 0.19x | CN¥2.31 Million | CN¥12.09 Million | CN¥2.31 Million | ▼ -85.9% |
| 2010 | 1.36x | CN¥2.58 Million | CN¥1.90 Million | CN¥2.58 Million | ▲ +555.4% |
| 2009 | 0.21x | CN¥3.70 Million | CN¥17.88 Million | CN¥3.70 Million | ▼ -7.5% |
| 2008 | 0.22x | CN¥4.80 Million | CN¥21.46 Million | CN¥4.80 Million | ▼ -52.7% |
| 2006 | 0.47x | CN¥15.90 Million | CN¥33.63 Million | CN¥15.90 Million | ▲ +26.5% |
| 2005 | 0.37x | CN¥7.07 Million | CN¥18.92 Million | CN¥7.07 Million | ▼ -42.4% |
| 2004 | 0.65x | CN¥17.45 Million | CN¥26.90 Million | CN¥17.45 Million | ▲ +33.8% |
| 2003 | 0.48x | CN¥22.88 Million | CN¥47.20 Million | CN¥22.88 Million | ▼ -84.4% |
| 2002 | 3.11x | CN¥102.14 Million | CN¥32.85 Million | CN¥102.14 Million | ▼ -39.7% |
| 2001 | 5.15x | CN¥79.72 Million | CN¥15.47 Million | CN¥79.72 Million | ▼ -10.6% |
| 2000 | 5.76x | CN¥118.45 Million | CN¥20.55 Million | CN¥118.45 Million | ▼ -79.5% |
| 1999 | 28.15x | CN¥63.25 Million | CN¥2.25 Million | CN¥63.25 Million | — |